Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 1,024,335 9.990% |
-8,196,337 (-88.89%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
Commodore Capital LP | 1,831,746 3.500% |
1,831,746 (New Position) |
Filing History |
| 2024-02-14 07:02 am Purchase |
2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 9,220,672 9.990% |
9,220,672 (New Position) |
Filing History |
| 2024-02-14 06:28 am Sale |
2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
Radcliffe Capital Management L.P. | 0 0.000% |
-62,756 (Position Closed) |
Filing History |
| 2023-12-04 4:33 pm Purchase |
2023-11-22 | 13G | SAB Biotherapeutics, Inc. SABS |
BIOTECHNOLOGY VALUE FUND L P | 917,828 9.990% |
917,828 (New Position) |
Filing History |
| 2023-10-16 4:05 pm Purchase |
2023-10-04 | 13G | SAB Biotherapeutics, Inc. SABS |
Commodore Capital LP | 693,246 9.900% |
693,246 (New Position) |
Filing History |
| 2022-12-16 4:33 pm Purchase |
2022-12-07 | 13D | SAB Biotherapeutics, Inc. SABS |
HAMILTON CHRISTINE E | 871,205 17.300% |
9,880 (+1.15%) |
Filing History |
| 2022-09-08 5:07 pm Purchase |
2022-09-07 | 13D | SAB Biotherapeutics, Inc. SABS |
Sullivan Eddie Joe | 571,911 13.300% |
1,400 (+0.25%) |
Filing History |
| 2022-09-08 5:04 pm Sale |
2022-06-07 | 13D | SAB Biotherapeutics, Inc. SABS |
HAMILTON CHRISTINE E | 861,324 20.000% |
-207,274 (-19.40%) |
Filing History |
| 2022-05-27 4:24 pm Sale |
2022-05-20 | 13D | SAB Biotherapeutics, Inc. SABS |
Big Cypress Holdings LLC | 96,530 2.200% |
-208,403 (-68.34%) |
Filing History |
| 2022-02-14 06:09 am Purchase |
2021-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
Radcliffe Capital Management L.P. | 62,756 1.440% |
62,756 (New Position) |
Filing History |
| 2022-02-11 3:39 pm Unchanged |
2021-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
BASSO CAPITAL MANAGEMENT L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-11-01 7:38 pm Purchase |
2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS |
Big Cypress Holdings LLC | 304,933 7.000% |
304,933 (New Position) |
Filing History |
| 2021-11-01 4:57 pm Purchase |
2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS |
HAMILTON CHRISTINE E | 1,068,598 24.580% |
1,068,598 (New Position) |
Filing History |
| 2021-11-01 4:55 pm Purchase |
2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS |
Sullivan Eddie Joe | 570,511 13.120% |
570,511 (New Position) |
Filing History |
| 2021-10-19 09:51 am Purchase |
2021-10-13 | 13G | Big Cypress Acquisition Corp. BCYP |
Radcliffe Capital Management L.P. | 1,296,891 8.770% |
1,296,891 (New Position) |
Filing History |
| 2021-02-24 10:00 am Purchase |
2021-02-22 | 13G | Big Cypress Acquisition Corp. BCYP |
BASSO CAPITAL MANAGEMENT L.P. | 757,794 5.120% |
757,794 (New Position) |
Filing History |